Skip to content
  • Seraspec®
  • About Us
  • Management Team
  • Directors & Advisors
  • In the News
  • Careers
  • Contact Us

Category: Release

Dr. Creager Joins Seraph’s Board of Directors

seraspec June 11, 2021
Source: Seraph Biosciences, Inc.

Dr. Creager Joins Seraph’s Board of Directors DETROIT, June 11, 2021 – Dr. Richard S. Creager, an established executive and consultant in the In Vitro […]

Dr. Ishaque Joins Seraph’s Board of Directors

seraspec May 3, 2021
Source: Seraph Biosciences, Inc.

Dr. Ishaque Joins Seraph’s Board of Directors DETROIT, May 3, 2021 – Dr. Nadeem Ishaque, former Chief Innovation Officer of GE Healthcare, joined Seraph’s Board […]

Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19

seraspec January 16, 2021
Source: Seraph Biosciences, Inc.

Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19 During the World War II era, MIT’s “Rad Lab” gave birth to […]

Seraph Vice President Gives Featured Interview with George Mason University

seraspec October 13, 2020
Source: George Mason University

Seraph Vice President Gives Featured Interview with George Mason University This month Shane Trexler, Seraph’s Vice President of Engineering and an alumnus of George Mason […]




Seraph Awarded Diagnostic Development Initiative Grant

seraspec September 14, 2020
Source: Seraph Biosciences, Inc.

Seraph Awarded Diagnostic Development Initiative Grant (DETROIT) – Seraph Biosciences, Inc. (“Seraph”), creator of Seraspec®, was recently awarded promotional credits from Amazon Web Services (“AWS”) […]

Combatting COVID-19

seraspec June 3, 2020
Source: Seraph Biosciences, Inc.

Seraph Chairman helps lead Detroit testing efforts for COVID-19 (DETROIT) –The devastating impact of the COVID-19 pandemic is far reaching, claiming countless lives and putting […]

Seraph Names Fouad Sayegh as Product VP

seraspec February 21, 2020
Source: Seraph Biosciences, Inc.

Seraph Names Fouad Sayegh as Product VP DETROIT, February 21, 2020 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to welcome Mr. Fouad Sayegh […]

BioIntelligence Revolution

seraspec July 2, 2019
Source: TEDxWayneStateU

TEDx Unveils “The BioIntelligence Revolution” The TEDx program has officially released Seraph Chairman, Dr. Charles Shanley’s second TEDx talk on the “BioIntelligence Revolution”. The talk […]

No Time to Wait

seraspec June 15, 2019
Source: World Health Organization

World Health Organization This past April, the World Health Organization’s Interagency Coordination Group on Antimicrobial Resistance (the “IAGC”) released a report to the Secretary-General of […]

Seraph Closes $4.2 Million Series B

seraspec April 28, 2019
Source: Seraph Biosciences, Inc.

Seraph Closes $4.2 Million Series B Round DETROIT, April 28, 2019 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to announced that it has […]

Dr. Loveman Joins Seraph’s Board

seraspec February 19, 2019
Source: Seraph Biosciences, Inc.

Dr. Gary Loveman Joins Seraph’s Board DETROIT, Feb. 19, 2019 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to announced that Dr. Gary Loveman, […]

Seraph Signs Deal with Zomedica

seraspec May 15, 2018
Source: Crain's Detroit Business

Seraph Biosciences signs deal with Zomedica on pathogen identifier device Seraph Biosciences Inc., a Detroit-based biomedical device company based at Wayne State University, has signed […]

Media inquiries

Lisa Vallee-Smith, Airfoil Group
vallee-smith@airfoilgroup.com
313-363-9981

Recent Posts

  • Seraph Enhances Board of Directors
  • Seraph Welcomes Dr. Hür Köser!
  • Dr. Creager Joins Seraph’s Board of Directors
  • Dr. Ishaque Joins Seraph’s Board of Directors
  • Nature Biotechnology: Radical Solutions
  • From Theory to Practice: A Profile on Seraph’s Advanced Quality Engineer
  • Seraph Scientist publishes research on novel diagnostic methods
  • Seraspec®
  • About Us
  • Management Team
  • Directors & Advisors
  • In the News
  • Careers
  • Terms and Conditions
  • Media Inquiries
  • Contact Us
1001 Woodward Ave. Suite 500 | Detroit, MI 48226 | 313.759.8009 | Seraph Biosciences, Inc.
Top